ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0894

HOXD13 Regulation of Primary Cilia in Rheumatoid Arthritis Synovial Fibroblasts: Implications for Joint-Specific Pathogenesis

Masoumeh Mirrahimi1, Kerstin Klein2, Alexandra Khmelevskaya3, Eva Camarillo Retamosa3, Miranda Houtmen3, Oliver Distler1 and Caroline Ospelt1, 1Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland, Zurich, Switzerland, 2University of Bern, Bern, Switzerland, 3Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland, Zurich, Zurich, Switzerland

Meeting: ACR Convergence 2024

Keywords: Fibroblasts, Synovial, Gene Expression, Inflammation, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Genetics, Genomics & Proteomics Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Rheumatoid arthritis (RA) follows a characteristic pattern of joint involvement. The embryonic development of limbs and joints influences certain joints’ propensity to develop arthritis. We previously demonstrated that the Homeobox HOXD13 transcription factor is highly differentially expressed between joint locations and can accurately assign synovial fibroblasts (SFs) to their correct joint location.
Our study aims to decipher the functional differences in SFs from MCP/PIP II-V and knee joints in relation to HOXD13 expression.

Methods: Hand synovial tissues were isolated from RA patients (n=7-12). SFs were cultured and transfected with HOXD13 GapmeR or control GapmeR. RNA was extracted and sequenced on the NovaSeq platform (n=3). qPCR confirmed differentially expressed genes (n=8-12). Primary cilia-associated genes were obtained from UniProtKB using the keyword Cilium (KW-0969). Gene set enrichment analysis and signature expression scores were calculated for HOXD13-silenced hand SFs and bulk RNA sequencing data from unstimulated and TNF-stimulated cells (n=3-5). Primary cilium measurements were performed in serum-starved RA SFs from knee (n=3) and hand (n=5) using immunofluorescence microscopy with acetylated alpha-tubulin. Images were acquired on the CellInsight CX7 platform. A watershed algorithm was used for image segmentation, quantifying primary cilia in 3,000 to 5,000 cells per patient.

Results: Analysis of HOXD13 differentially expressed genes (DEGs) revealed enrichment of terms related to primary cilia assembly and organization (FDR < 0.05, |log2FC| > 20%). HOXD13 targeted about 31% of the ciliary genes (FDR = 0.015, |log2FC| > 20%) (Fig. 1A), mainly downregulating genes involved in ciliogenesis and ciliary trafficking (Fig. 1B). Acetylated alpha-tubulin immunostaining visualized the primary cilium in control cells but showed hyperacetylation of cytoplasmic microtubules in HOXD13-silenced SFs (Fig. 1C). This was followed by downregulation of key ciliary genes (KIF3A, IFT88) after HOXD13 silencing (Fig. 1D).

DEGs between RA SFs from hand and knee showed terms associated with primary cilium (FDR < 0.05, |log2FC| > 20%). There was significant enrichment of the cilium gene signature in MCP-Knee DEGs (FDR = 0.03). Following in vitro TNF stimulation, genes involved in ciliogenesis and ciliary trafficking were dysregulated, especially in hand SFs (FDR < 0.05, |log2FC| > 20%). Serum-starved SFs from different joints consistently had 75%-100% ciliated cells, regardless of origin (Fig. 1E). However, primary cilia were significantly shorter/more upright in serum-starved hand SFs compared to longer/more inclined ones in knee SFs (Fig. 1F). Joint-specific expression patterns of ciliary genes KIF3A and IFT88 were confirmed by qPCR (Fig. 1G).

Conclusion: Our findings suggest HOXD13 plays a pivotal role in ciliary biogenesis in hand SFs and may be responsible for observed ciliary differences between hand and knee SFs. Given the importance of primary cilia in various biological processes, we hypothesize that HOXD13 regulates fibroblast functions through the primary cilium, creating a joint-specific environment that influences the development and progression of RA in specific joints.

Supporting image 1

Figure.1 Abbreviations: log2FC = log2 fold-change, RA = rheumatoid arthritis, SF = synovial fibroblasts.


Disclosures: M. Mirrahimi: None; K. Klein: None; A. Khmelevskaya: None; E. Camarillo Retamosa: None; M. Houtmen: None; O. Distler: 4P-Pharma, 2, “mir-29 for the treatment of systemic sclerosis” (US8247389, EP2331143), 10, AbbVie, 2, Acceleron, 2, Alcimed, 2, Altavant Sciences, 2, Amgen, 2, AnaMar, 2, Arxx, 2, AstraZeneca, 2, Bayer, 2, 6, Blade Therapeutics, 2, Boehringer Ingelheim, 2, 5, 6, Citrus AG, 12, Co-founder, Corbus Pharmaceuticals, 2, CSL Behring, 2, EMD Serono, 2, ERS/EULAR Guidelines, 12, Co-Chair, EUSTAR, 12, President, FOREUM Foundation, 12, Chair of Executive Committee, Galapagos, 2, Glenmark, 2, Gossamer, 2, Hartmann Müller Foundation, 12, Member Board of Trustees, Horizon, 2, Janssen, 2, 6, Kymera, 2, 5, Lupin, 2, Medscape, 2, 6, Merck/MSD, 2, Miltenyi Biotec, 2, Mitsubishi Tanabe, 2, 5, Nkarta Inc., 2, Novartis, 2, Orion, 2, Prometheus Biosciences, 2, Redxpharma, 2, Roivant, 2, Swiss Academy of Medical Sciences, 12, Senat Member, Swiss Clinical Quality Management in Rheumatic Diseases, 12, Member Board of Trustees, Topadur, 2, UCB, 2; C. Ospelt: Novartis, 6.

To cite this abstract in AMA style:

Mirrahimi M, Klein K, Khmelevskaya A, Camarillo Retamosa E, Houtmen M, Distler O, Ospelt C. HOXD13 Regulation of Primary Cilia in Rheumatoid Arthritis Synovial Fibroblasts: Implications for Joint-Specific Pathogenesis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/hoxd13-regulation-of-primary-cilia-in-rheumatoid-arthritis-synovial-fibroblasts-implications-for-joint-specific-pathogenesis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hoxd13-regulation-of-primary-cilia-in-rheumatoid-arthritis-synovial-fibroblasts-implications-for-joint-specific-pathogenesis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology